Envista Holdings (NVST) Depreciation and Depletion (2018 - 2026)
Envista Holdings (NVST) recorded quarterly Depreciation and Depletion of $10.4 million in Q2 2026, up 2.97% quarter-over-quarter from $10.1 million in Q4 2025, and up 14.29% on a YoY basis from $9.1 million in Q2 2025.
Envista Holdings (NVST) Depreciation and Depletion (2018 - 2026) Analysis & Trends
Envista Holdings' Depreciation and Depletion history runs 9 years deep, the most recent figure standing at $10.4 million for Q2 2026.
- In Q2 2026, Depreciation and Depletion rose 14.29% year-over-year to $10.4 million; the TTM figure through Apr 2026 stood at $41.4 million (up 2.48% YoY), while the FY2025 annual figure was $40.1 million, down 1.72% from the prior year.
- Depreciation and Depletion was $10.4 million for Q2 2026 at Envista Holdings, up from $10.1 million in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $11.6 million in Q2 2024 to a low of $7.8 million in Q3 2022.
- Historically, Depreciation and Depletion has averaged $9.4 million across 5 years, with a median of $9.2 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Depreciation and Depletion plunged 30.7% in 2022, then rose 23.4% in 2024.
- A 5-year view of Depreciation and Depletion shows it stood at $7.9 million in 2022, then climbed by 16.46% to $9.2 million in 2023, then changed by 0.0% to $9.2 million in 2024, then increased by 9.78% to $10.1 million in 2025, then rose by 2.97% to $10.4 million in 2026.
- The last three Depreciation and Depletion figures came in at $10.4 million (Q2 2026), $10.1 million (Q4 2025), and $10.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | - |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | - |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 44.60 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 38.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 47.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 15.60 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 91.00 Mn |
| 10 | Envista Holdings | 4.06 Bn | 2.98 Bn | 390.10 Mn | 10.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 10.40 Mn |
| Apr 3, 2026 | 10.40 Mn |
| Dec 31, 2025 | 10.10 Mn |
| Dec 31, 2025 | 10.10 Mn |
| Sep 26, 2025 | 10.10 Mn |
| Sep 26, 2025 | 10.10 Mn |
| Jun 27, 2025 | 10.80 Mn |
| Jun 27, 2025 | 10.80 Mn |
| Mar 28, 2025 | 9.10 Mn |
| Mar 28, 2025 | 9.10 Mn |
| Dec 31, 2024 | 9.20 Mn |
| Dec 31, 2024 | 9.20 Mn |
| Sep 27, 2024 | 10.50 Mn |
| Sep 27, 2024 | 10.50 Mn |
| Jun 28, 2024 | 11.60 Mn |
| Jun 28, 2024 | 11.60 Mn |
| Mar 29, 2024 | 9.50 Mn |
| Mar 29, 2024 | 9.50 Mn |
| Dec 31, 2023 | 9.20 Mn |
| Dec 31, 2023 | 9.20 Mn |